References

Widespread pain is a risk factor for cardiovascular mortality: results from the Framingham Heart Study

10.1093/eurheartj/ehz111 · 2019 · External reference

The association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease in the UK Biobank

10.1093/eurjpc/zwac127 · 2022 · External reference

Genetic liability to multi-site chronic pain increases the risk of cardiovascular disease

10.1016/j.bja.2023.04.020 · 2023 · External reference

Ropivacaine and celecoxib-loaded injectable composite hydrogel for improved chronic pain-exacerbated myocardial ischemia-reperfusion injury

10.1016/j.jconrel.2025.01.028 · 2025 · External reference

Cellular circuits in the brain and their modulation in acute and chronic pain

10.1152/physrev.00040.2019 · 2020 · External reference

Brain circuits for pain and its treatment

10.1126/scitranslmed.abj7360 · 2021 · External reference

Chronic pain-related changes in cardiovascular regulation and impact on comorbid hypertension in a general population: the Tromsø study

10.1097/j.pain.0000000000001070 · 2018 · External reference

Modulating neuroplasticity for chronic pain relief: noninvasive neuromodulation as a promising approach

10.1038/s12276-025-01409-0 · 2025 · External reference

Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury

10.1161/01.cir.104.3.253 · 2001 · External reference

Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study

10.1161/01.cir.0000155252.23933.2d · 2005 · External reference

Sympathetic neural overdrive, aortic stiffening, endothelial dysfunction, and impaired exercise capacity in severe COVID-19 survivors: a mid-term study of cardiovascular sequelae

10.1161/hypertensionaha.122.19958 · 2023 · External reference

Artery-associated sympathetic innervation drives rhythmic vascular inflammation of arteries and veins

10.1161/circulationaha.119.040232 · 2019 · External reference

Heart rate variability in myocardial infarction and heart failure

10.1016/j.ijcard.2006.11.221 · 2007 · External reference

Cardiac sympathetic denervation to prevent life-threatening arrhythmias

10.1038/nrcardio.2014.19 · 2014 · External reference

The NLRP3 inflammasome: contributions to inflammation-related diseases

10.1186/s11658-023-00462-9 · 2023 · External reference

Role of β adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis

10.1016/j.ejheart.2007.11.008 · 2008 · External reference

Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction

10.7150/thno.47021 · 2021 · External reference

LPA2 contributes to vascular endothelium homeostasis and cardiac remodeling after myocardial infarction

10.1161/circresaha.122.321036 · 2022 · External reference

Flow-induced reprogramming of endothelial cells in atherosclerosis

10.1038/s41569-023-00883-1 · 2023 · External reference

Sympathetic nerve activity and neuro-inflammation: who is in the driver’s seat?

10.1111/apha.13011 · 2017 · External reference

AMPK attenuation of β-adrenergic receptor-induced cardiac injury via phosphorylation of β-arrestin-1-ser330

10.1161/circresaha.124.324762 · 2024 · External reference

Multicenter, prospective, randomized controlled trial of high-sensitivity cardiac troponin I-guided combination angiotensin receptor blockade and beta-blocker therapy to prevent anthracycline cardiotoxicity: the Cardiac CARE trial

10.1161/circulationaha.123.064274 · 2023 · External reference

NLRP3 inflammasome activation through heart-brain interaction initiates cardiac inflammation and hypertrophy during pressure overload

10.1161/circulationaha.122.060860 · 2023 · External reference

Mechanism and regulation of NLRP3 inflammasome activation

10.1016/j.tibs.2016.09.002 · 2016 · External reference